Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Common stock subscribed but not issued
Additional paid-in capital
Accumulated deficit
Non- controlling interests
Beginning balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Beginning balance at Dec. 31, 2022 $ 57,310 $ 341 $ 39 $ 142,365 $ (83,924) $ (1,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock subscribed but not issued (in shares)     5,025      
Common stock subscribed but not issued 2   $ 2      
Issuance of subscribed shares (in shares)   70,000 (70,000)      
Issuance of subscribed shares 0   $ (39) 39    
Standalone warrants issued as payment for services 5,454     5,454    
Shares issued as purchase consideration - business acquisition (in shares)   6,580,390        
Shares issued as purchase consideration - business acquisition 2,994 $ 7   2,987    
Common stock issued under licensing agreement (in shares)   1,793        
Common stock issued under licensing agreement 1     1    
Distributions to non-controlling interests (34)         (34)
Stock-based compensation 206     206    
Net loss (income) (664)       (645) (19)
Ending balance (in shares) at Mar. 31, 2023   348,126,911 5,025      
Ending balance at Mar. 31, 2023 65,269 $ 348 $ 2 151,052 (84,569) (1,564)
Beginning balance (in shares) at Dec. 31, 2022   341,474,728 70,000      
Beginning balance at Dec. 31, 2022 57,310 $ 341 $ 39 142,365 (83,924) (1,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (income) (1,599)          
Ending balance (in shares) at Jun. 30, 2023   371,614,758 0      
Ending balance at Jun. 30, 2023 80,904 $ 372 $ 0 167,652 (85,527) (1,593)
Beginning balance (in shares) at Mar. 31, 2023   348,126,911 5,025      
Beginning balance at Mar. 31, 2023 $ 65,269 $ 348 $ 2 151,052 (84,569) (1,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of subscribed shares (in shares) 5,025   (5,025)      
Issuance of subscribed shares $ 0   $ (2) 2    
Exercise of stock options (in shares)   157,752        
Exercise of stock options 35     35    
Release of shares under stock grants (in shares)   349,999        
Release of shares under stock grants 0 $ 1   (1)    
Conversion of preferred stock to common stock (in shares)   21,383,040        
Conversion of preferred stock to common stock 15,823 $ 21   15,802    
Purchase of minority interests in certain of the Company's subsidiaries (in shares)   450,000        
Purchase of minority interests in certain of the Company’s subsidiaries 0 $ 1   4   (5)
Common stock issued to settle obligations (in shares)   400,000        
Common stock issued to settle obligations 160     160    
Common stock issued under licensing agreement (in shares)   1,290        
Common stock issued to purchase property and equipment (in shares)   740,741        
Common stock issued to purchase property and equipment 300 $ 1   299    
Distributions to non-controlling interests (47)         (47)
Stock-based compensation 299     299    
Net loss (income) (935)       (958) 23
Ending balance (in shares) at Jun. 30, 2023   371,614,758 0      
Ending balance at Jun. 30, 2023 80,904 $ 372 $ 0 167,652 (85,527) (1,593)
Beginning balance (in shares) at Dec. 31, 2023   375,126,352 0      
Beginning balance at Dec. 31, 2023 69,914 $ 375 $ 0 171,144 (99,955) (1,650)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of shares under stock grants (in shares)   335,300        
Common stock issued under licensing agreement (in shares)   3,614        
Common stock issued under licensing agreement 1     1    
Distributions to non-controlling interests (46)         (46)
Stock-based compensation 244     244    
Net loss (income) (1,292)       (1,298) 6
Ending balance (in shares) at Mar. 31, 2024   375,465,266 0      
Ending balance at Mar. 31, 2024 68,821 $ 375 $ 0 171,389 (101,253) (1,690)
Beginning balance (in shares) at Dec. 31, 2023   375,126,352 0      
Beginning balance at Dec. 31, 2023 $ 69,914 $ 375 $ 0 171,144 (99,955) (1,650)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 0          
Net loss (income) $ (2,931)          
Ending balance (in shares) at Jun. 30, 2024   380,338,790 0      
Ending balance at Jun. 30, 2024 68,603 $ 380 $ 0 172,842 (102,904) (1,715)
Beginning balance (in shares) at Mar. 31, 2024   375,465,266 0      
Beginning balance at Mar. 31, 2024 68,821 $ 375 $ 0 171,389 (101,253) (1,690)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of shares under stock grants (in shares)   950,707        
Release of shares under stock grants 0 $ 1   (1)    
Standalone warrants issued as payment for services 218     218    
Shares issued as purchase consideration - business acquisition (in shares)   3,917,267        
Shares issued as purchase consideration - business acquisition 991 $ 4   987    
Common stock issued under licensing agreement (in shares)   5,550        
Common stock issued under licensing agreement 1     1    
Distributions to non-controlling interests (37)         (37)
Stock-based compensation 248     248    
Net loss (income) (1,639)       (1,651) 12
Ending balance (in shares) at Jun. 30, 2024   380,338,790 0      
Ending balance at Jun. 30, 2024 $ 68,603 $ 380 $ 0 $ 172,842 $ (102,904) $ (1,715)